Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Optimism Grows for Toddlers with Peanut Allergies as Viaskin Patch Safety Study Begins

Study to Reduce Infants’ Life-Threatening Food Allergies at Risk Due to Federal Cuts

FAF Funding Four New Food Allergy Research Projects Working Toward Finding Treatments and a Cure

Dupilumab Lowered IgE Levels in Small Study

Children’s Response to Peanut Patch Therapy Increased Over 60 Months

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...

Aimmune Announces US FDA Advisory Committee Meeting Date for AR101 for...

Study: Peanut OIT Increases Allergic Reactions, Compared with Avoidance or Placebo

Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...

Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens

Must See: 'ViewFinder: Food for Thought – Food Allergies'

European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...

US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut...

Your School On Our Map

Put Your School on the Map